Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127558281 | 12755828 | 1 | I | 20150915 | 20160823 | 20160916 | 20160916 | EXP | PHHY2016TW128126 | NOVARTIS | 35.27 | YR | M | Y | 0.00000 | 20160916 | MD | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127558281 | 12755828 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 OT, UNK | U | 22068 | CAPSULE | ||||||||
| 127558281 | 12755828 | 2 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 500 MG, UNK | Y | 0 | 500 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127558281 | 12755828 | 1 | Chronic myeloid leukaemia |
| 127558281 | 12755828 | 2 | Prophylaxis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127558281 | 12755828 | Back pain | |
| 127558281 | 12755828 | Rash | |
| 127558281 | 12755828 | Rash pustular |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127558281 | 12755828 | 1 | 20150901 | 0 | ||
| 127558281 | 12755828 | 2 | 20160224 | 20160226 | 0 |